In-silico strategies for probing chloroquine based inhibitors against SARS-CoV-2

S Beura, P Chetti - Journal of Biomolecular Structure and …, 2021 - Taylor & Francis
The global health emergency of novel COVID-19 is due to severe acute respiratory
syndrome coronavirus-2 (SARS-CoV-2). Currently there are no approved drugs for the …

In-silico strategies for probing chloroquine based inhibitors against SARS-CoV-2

S Beura, P Chetti - Journal of biomolecular structure & …, 2021 - pubmed.ncbi.nlm.nih.gov
The global health emergency of novel COVID-19 is due to severe acute respiratory
syndrome coronavirus-2 (SARS-CoV-2). Currently there are no approved drugs for the …

In-silico strategies for probing chloroquine based inhibitors against SARS-CoV-2.

S Beura, P Chetti - Journal of Biomolecular Structure & Dynamics, 2020 - europepmc.org
The global health emergency of novel COVID-19 is due to severe acute respiratory
syndrome coronavirus-2 (SARS-CoV-2). Currently there are no approved drugs for the …

[PDF][PDF] In-silico strategies for probing chloroquine based inhibitors against SARS-CoV-2

S Beura, P Chetti - 2020 - academia.edu
The global health emergency of novel COVID-19 is due to severe acute respiratory
syndrome coronavirus-2 (SARS-CoV-2). Currently there are no approved drugs for the …

In-silico strategies for probing chloroquine based inhibitors against SARS-CoV-2

S Beura, P Chetti - Journal of Biomolecular Structure and …, 2021 - ingentaconnect.com
The global health emergency of novel COVID-19 is due to severe acute respiratory
syndrome coronavirus-2 (SARS-CoV-2). Currently there are no approved drugs for the …

[HTML][HTML] In-silico strategies for probing chloroquine based inhibitors against SARS-CoV-2

S Beura, P Chetti - Journal of Biomolecular Structure & Dynamics, 2020 - ncbi.nlm.nih.gov
The global health emergency of novel COVID-19 is due to severe acute respiratory
syndrome coronavirus-2 (SARS-CoV-2). Currently there are no approved drugs for the …

[引用][C] In-silico strategies for probing chloroquine based inhibitors against SARS-CoV-2

S Beura, P Chetti - Journal of Biomolecular Structure and Dynamics, 2020 - cir.nii.ac.jp
In-silico strategies for probing chloroquine based inhibitors against SARS-CoV-2 | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …

[PDF][PDF] In-silico strategies for probing chloroquine based inhibitors against SARS-CoV-2

S Beura, P Chetti - 2020 - researchgate.net
The global health emergency of novel COVID-19 is due to severe acute respiratory
syndrome coronavirus-2 (SARS-CoV-2). Currently there are no approved drugs for the …

In-silico strategies for probing chloroquine based inhibitors against SARS-CoV-2.

S Beura, P Chetti - Journal of Biomolecular Structure & Dynamics, 2020 - europepmc.org
The global health emergency of novel COVID-19 is due to severe acute respiratory
syndrome coronavirus-2 (SARS-CoV-2). Currently there are no approved drugs for the …